Literature DB >> 30779477

Platelet Flow Cytometry: Instrument Setup, Controls, and Panel Performance.

Benjamin E J Spurgeon1, Khalid M Naseem1.   

Abstract

Platelet flow cytometry is widely used in cardiovascular medicine as the platelet surface is rich in clinical biomarkers. Surface profiling is critical in disease management, but current assays can abet clinical errors as they are suboptimal and prone to bias. Accordingly, the technical and analytical advances that can be used to create high quality assays with minimal error and maximal sensitivity were reviewed. Specifically, the best practices for instrument setup, quality control, panel design, titration, gating, and compensation were described. Adherence to these practices will enhance the validity and reliability of platelet flow cytometry in clinical/research settings.
© 2019 International Clinical Cytometry Society. © 2019 International Clinical Cytometry Society.

Entities:  

Keywords:  blood platelets; cardiovascular diseases; flow cytometry; immunophenotyping; platelet function tests

Mesh:

Substances:

Year:  2019        PMID: 30779477     DOI: 10.1002/cyto.b.21774

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  4 in total

Review 1.  Flow Cytometry: From Experimental Design to Its Application in the Diagnosis and Monitoring of Respiratory Diseases.

Authors:  Julio Flores-Gonzalez; Juan Carlos Cancino-Díaz; Leslie Chavez-Galan
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

Review 2.  The Underestimated Role of Platelets in Severe Infection a Narrative Review.

Authors:  Alberto Fogagnolo; Gianluca Calogero Campo; Matilde Mari; Graziella Pompei; Rita Pavasini; Carlo Alberto Volta; Savino Spadaro
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

Review 3.  Novel Techniques and Future Perspective for Investigating Critical-Size Bone Defects.

Authors:  Elijah Ejun Huang; Ning Zhang; Huaishuang Shen; Xueping Li; Masahiro Maruyama; Takeshi Utsunomiya; Qi Gao; Roberto A Guzman; Stuart B Goodman
Journal:  Bioengineering (Basel)       Date:  2022-04-11

4.  Circular RNA Rbms1 inhibited the development of myocardial ischemia reperfusion injury by regulating miR-92a/BCL2L11 signaling pathway.

Authors:  Ling Jin; Yuan Zhang; Yun Jiang; Mingjuan Tan; Caidong Liu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.